Millington Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,436
Closed -$1.07M 80
2023
Q3
$1.07M Sell
10,436
-449
-4% -$48.4K 0.96% 34
2023
Q2
$1.26M Sell
10,885
-50
-0.5% -$5.68K 1.12% 28
2023
Q1
$1.16M Buy
10,935
+256
+2% +$27.6K 1.08% 31
2022
Q4
$1.18M Buy
+10,679
New +$1.09M 1.16% 27

Other funds holding MRK

Millington Financial Advisors's MRK Position: Q4 2023 in Review

Millington Financial Advisors sold out of Merck (MRK) in Q4 2023, closing a stake of 10,436 shares — an estimated $1.07M sold.

Millington Financial Advisors first reported a position in MRK in Q4 2022 and held it in 4 quarters. The position peaked at $1.26M in Q2 2023. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Millington Financial Advisors reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Millington Financial Advisors sold 10,436 Merck shares in Q4 2023, an estimated $1.07M.
  • Millington Financial Advisors first reported a position in Merck in Q4 2022 and held it in 4 quarters.
  • Millington Financial Advisors's Merck position peaked at $1.26M in Q2 2023.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Millington Financial Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.